Directori de persones
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grau: Doctor

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicacions

  • Borràs, Mercè; Cambray, Serafí; Crespo-Masip, Maria; Pérez-Fontán, Miguel; Bozic, Milica; Bermudez-López, Marcelino; Fernández, Elvira; Betriu, Àngels; Valdivielso, José M.

    Peritoneal Dialysis Is an Independent Factor Associated to Lower Intima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease

    Frontiers in physiology 9 1743-1743. .

    [doi:10.3389/fphys.2018.01743]

  • Ferro CJ; Mark PB; Kanbay M; Sarafidis P; Heine GH; Rossignol P; Massy ZA; Mallamaci F; Valdivielso JM; Malyszko J; Verhaar MC; Ekart R; Vanholder R; London G; Ortiz A; Zoccali C

    Lipid management in patients with chronic kidney disease

    NAT REV NEPHROL 14 727-749. .

    [doi:10.1038/s41581-018-0072-9]

  • Montserrat-Capdevila J; Seminario MA; Godoy P; Marsal JR; Ortega M; Pujol J; Castañ MT; Alsedà M; Betriu À; Lecube A; Portero M; Purroy F; Valdivielso JM; Barbé F

    Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors

    MEDICINA CLINICA 151 383-389. .

    [doi:10.1016/j.medcli.2017.12.018]

  • Arcidiacono MV; Rimondi E; Maietti E; Melloni E; Tisato V; Gallo S; Valdivielso JM; Fernández E; Betriu À; Voltan R; Zauli G; Volpato S; Secchiero P

    Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease

    PLOS ONE 13 e0203716-. .

    [doi:10.1371/journal.pone.0203716]

  • Palanca, A; Castelblanco, E; Perpinan, H; Betriu, A; Soldevila, B; Valdivielso, JM; Bermudez, M; Duran, X; Fernandez, E; Puig-Domingo, M; Groop, PH; Alonso, N; Mauricio, D

    Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes

    Atherosclerosis 276 50-57. .

    [doi:10.1016/j.atherosclerosis.2018.07.018]

  • Sans, MB; Perez-Fontan, M; Martinez-Alonso, M; Bajo, A; Betriu, A; Valdivielso, JM; Fernandez, E; NEFRONA Investigators

    The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease (vol 12, e0186921, 2017)

    PLOS ONE 13 e0200226-. .

    [doi:10.1371/journal.pone.0200226]

  • Crespo-Masip, M; Perez, A; Garcia, A; Munoz-Castaneda, JR; Rodriguez, JM; Fernandez, E; Valdivielso, JM

    PTEN INDUCIBLE KO MICE SHOW ALTERED MINERAL METABOLISM

    NEPHROLOGY DIALYSIS TRANSPLANTATION 33 -. .

  • Caus, M; Bozic, M; Fernandez, E; Valdivielso, JM

    DELETION OF VITAMIN D RECEPTOR EXCLUSIVELY IN VASCULAR SMOOTH MUSCLE CELLS PREVENTS VASCULAR CALCIFICATION

    NEPHROLOGY DIALYSIS TRANSPLANTATION 33 159-159. .

  • Palau, V; Riera, M; Benito, D; Duran, X; Valdivielso, JM; Rodriguez, E; Betriu, MA; Fernandez, E; Pascual, J; Soler, MJ

    ROLE OF CIRCULATING ADAM17 ACTIVITY IN CHRONIC KIDNEY DISEASE

    NEPHROLOGY DIALYSIS TRANSPLANTATION 33 46-46. .

  • Palau, V; Riera, M; Benito, D; Duran, X; Valdivielso, JM; Betriu, MA; Fernandez, E; Pascual, J; Soler, MJ

    CIRCULATING ADAM17 ACTIVITY AS A MARKER OF CV EVENTS IN CKD PATIENTS

    NEPHROLOGY DIALYSIS TRANSPLANTATION 33 131-131. .

  • Bozic M; Betriu A; Bermudez-Lopez M; Ortiz A; Fernandez E; Valdivielso JM

    Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients

    Clinical Journal Of The American Society Of Nephrology 13 577-584. .

    [doi:10.2215/CJN.07980717]

  • Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM; investigators from the NEFRONA study

    Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease

    Atherosclerosis 270 13-20. .

    [doi:10.1016/j.atherosclerosis.2018.01.011]

Projectes

  • Red de investigación Renal: REDINREN
  • Papel de la expresión renal de alfa sinucleina en la enfermedad renal crónica. Implicaciones en la patogénesis de la fibrosis renal
  • MOVILIDAD DE PROFESIONALES SANITARIOS E INVESTIGADORES DEL SNS (M-BAE)
  • IDENTIFYING PREDICTORS OF CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. A COHORTS SUBSTUDY WITHIN THE NEFRONA STUDY
  • ESTANCIAS DE PROFESORES E INVESTIGADORES SENIORES EN CENTROS EXTRANJEROS, PROGRAMA SALVADOR DE MADARIAGA 2012
  • PAPEL DE LA FALTA DE VITAMINA D EN LA PROGRESION DE LA PLACA ATEROSCLEROTICA. IMPLICACIONES ENF LA ARTERIOPATIA UREMICA
  • PAPEL DEL RECEPTOR DE VITAMINA D EN LA PROGRESION DEL CICLO CELULAR Y LA SENESCENCIA DE LAS CELULAS DE MUSCULO LISO VASCULAR. IMPLICACIONES EN LA FORMACION DE PLACA DE ATEROMA.
  • REGULACION DE LA SINTESIS VASCULAR DE CALCITRIOL EN CONDICIONES NORMALES EN LA UREMIA. EFECTOS DEL TRATAMIENTO CON VITAMINA D Y ANALOGOS
  • ROLE OF VDR ON VASCULAR SMOOTH CELLS BIOLOGY
  • PAPEL DE LOS RECEPTORES RENALES DE NMDA EN EL FRACASO RENAL EXPERIMENTAL. RELACION CON EL NO.
  • Papel de los receptores renales de NMDA en el fracaso renal experimental. Relación con el NO
  • PAPEL DE LA 1-25 DIHIDROXIVITAMINA D3 EXTRARRENAL EN LA PROGRESION DE LA ARTERIOPATIA UREMICA